Telix QSAM Inc (QSAM)

[Gentlemen Prefer Bonds]

This is incorrect information in need of a fact check. QSAM is due to file their 10-Q soon, so hopefully there is more information in the filing.

The information you are incorrect on is the time frame of the FDA process. Cyclosam is already approved by the FDA for pain and is being marketed as Quadramet. QSAM licensed it from the patent holders and will be seeking FDA approval for a new verion of an approved drug. No guarantees, but there is no way the Phase 1 trials will be three years.

I like this new direction. There will be many bumps in the road, but I think QSAM has some potential.